News
Peptides aren’t entirely new to medicine. The first peptide drug – insulin – was isolated in 1921 and became commercially ...
Thanjavur: The District Consumer Disputes Redressal Commission, Thanjavur, recently directed a Tambaram-based private ...
18h
Migraine Again on MSNCan Prednisone Relieve Your Stubborn Migraine Pain? What You Should Know
Learn how prednisone can provide relief from a stubborn migraine attack or cluster headache cycle when other treatments ...
Tildrakizumab is an interleukin-23 antagonist approved under the brand name Ilumya for the treatment of plaque psoriasis.
With new systemic treatments now available for psoriatic disease, questions remain on the comparable efficacy and safety of these therapies.
Several studies have now demonstrated that trained immunity occurs in the airways to several pathogens and products, while its utility is yet to be determined.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results